HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone.

AbstractBACKGROUND:
Propyphenazone (1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)-2-phenyl-3H-pyrazol-3-one; PP) is a nonsteroidal anti-inflammatory drug frequently used as mild analgesic medicament. It belongs to the chemical group of pyrazolones. Severe adverse reactions to PP are frequent and have generally been regarded as pseudoallergic or intolerance reactions. Presently, there are no useful in vitro test systems available for the detection of antibodies directed against analgesic drugs.
OBJECTIVE:
The purpose of this study was to unequivocally demonstrate that IgE-mediated Type I allergy is the main mechanism leading to immediate-type adverse reactions to the analgesic drug PP.
METHODS:
We investigated 53 young adult patients with adverse reactions to PP. All patients developed symptoms suggestive of IgE-mediated anaphylaxis within 30 minutes after intake of a painkiller containing PP. Patients were subjected to skin tests (prick test and intracutaneous test). In addition, a novel ELISA system was developed to prove the existence of specific IgE antibodies in patients' sera.
RESULTS:
In 44 of 53 (83%) patients, skin tests showed typical wheal and flare reactions. Significant amounts of PP-specific serum IgE was detected in 31 of 53 (58%) of the serum samples. Moreover, in 7 of 9 patients with skin test negative results, PP-specific IgE could be detected. The assay was PP-specific because only PP, but no other pyrazolone derivative (antipyrine, aminophenazone, or metamizol), was able to inhibit IgE-binding in the system.
CONCLUSION:
Propyphenazone is a sensitizing agent in susceptible individuals and can elicit IgE-mediated anaphylaxis. By using skin tests and our ELISA system we were able to confirm Type I allergy in 51 of 53 (96%) patients in this study.
AuthorsMartin Himly, Beatrice Jahn-Schmid, Klaus Pittertschatscher, Barbara Bohle, Karl Grubmayr, Fátima Ferreira, Herwig Ebner, Christof Ebner
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 111 Issue 4 Pg. 882-8 (Apr 2003) ISSN: 0091-6749 [Print] United States
PMID12704373 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin E
  • propyphenazone
  • Antipyrine
Topics
  • Adolescent
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal (adverse effects)
  • Antipyrine (adverse effects, analogs & derivatives)
  • Drug Hypersensitivity (etiology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Hypersensitivity, Immediate (etiology)
  • Immunoblotting
  • Immunoglobulin E (immunology)
  • Male
  • Middle Aged
  • Skin Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: